Addison Advisors’s iShares iBonds Dec 2030 Term Corporate ETF IBDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$204K Sell
9,370
-2,095
-18% -$45.7K 0.1% 116
2026
Q1
$251K Buy
11,465
+245
+2% +$5.4K 0.06% 192
2025
Q4
$248K Hold
11,220
0.06% 187
2025
Q3
$249K Hold
11,220
0.06% 194
2025
Q2
$247K Buy
11,220
+2,535
+29% +$54.9K 0.06% 189
2025
Q1
$189K Buy
8,685
+1,760
+25% +$37.8K 0.05% 217
2024
Q4
$148K Sell
6,925
-480
-6% -$10.4K 0.04% 248
2024
Q3
$164K Buy
7,405
+480
+7% +$10.5K 0.05% 247
2024
Q2
$147K Buy
6,925
+4,605
+198% +$97.3K 0.05% 242
2024
Q1
$49.6K Buy
2,320
+400
+21% +$8.55K 0.02% 369
2023
Q4
$41.5K Buy
1,920
+1,750
+1,029% +$36.2K 0.02% 378
2023
Q3
$3.46K Buy
+170
New +$3.54K ﹤0.01% 561

Other funds holding IBDV

Addison Advisors's IBDV Position: Q2 2026 in Review

Addison Advisors reduced its iShares iBonds Dec 2030 Term Corporate ETF (IBDV) stake by 18% in Q2 2026, selling an estimated $45.7K and leaving 9,370 shares worth $204K. The position accounts for 0.1% of the portfolio, ranked #116.

Addison Advisors first reported a position in IBDV in Q3 2023 and has held it in 12 quarters since. The position peaked at $251K in Q1 2026. 349 funds tracked by Wall St. Rank hold IBDV as of Q2 2026.

  • Addison Advisors held 9,370 shares of iShares iBonds Dec 2030 Term Corporate ETF worth $204K as of Q2 2026.
  • Addison Advisors sold 2,095 iShares iBonds Dec 2030 Term Corporate ETF shares in Q2 2026, an estimated $45.7K.
  • iShares iBonds Dec 2030 Term Corporate ETF made up 0.1% of Addison Advisors's portfolio in Q2 2026, its #116 holding.
  • Addison Advisors first reported a position in iShares iBonds Dec 2030 Term Corporate ETF in Q3 2023 and has held it in 12 quarters since.
  • Addison Advisors's iShares iBonds Dec 2030 Term Corporate ETF position peaked at $251K in Q1 2026.
  • 349 funds tracked by Wall St. Rank held iShares iBonds Dec 2030 Term Corporate ETF as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.